Search

linkedin post 2021-12-12 06:24:35

EPIGENETIC SILENCERS. “Moreover, in 126 cases of several types of hematologic malignancies, Bmal1 gene silencing due to CpG promoter methylation was found in 19.7% of diffuse large B cell lymphomas, 33.3% of acute lymphocytic leukemias, and 19.2% of acute myeloid leukemias.”

https://www.nature.com/articles/s41591-018-0271-8?fbclid=IwAR01C2Z4J5lxVYDLhxIb9dPb3fhNSZSxwimZvhHaJ4n3-nVPpkt2PNqoukk

View in LinkedIn

Share the knowledge
Share the knowledge

SEARCH:

Search

CATEGORIES:

IT MIGHT BE OF YOUR INTEREST: